Thank you!
It is time to say thank you for an eventful and turbulent year. We are pleased to have been able to start building our RAYDIAX company in 2021 to advance global cancer treatment with our TACT system. A particular “Thank You” goes to the German Federal Ministry of Economics and Climate Action for making our first round of funding possible! In addition, we are very pleased that our clinical and technical partners have always been there with their expertise to support us on this new path.
We wish you all a merry Christmas season, relaxing holidays and a healthy and successful year 2022. We look forward to our continued collaboration!
See you in 2022.Team RAYDIAX
Ready for Innovation?
We know that the methods of minimally invasive therapies continue to offer great potential for clinical innovation. Would you also like to establish your operating technique? Make a suggestion, define a joint project and research your case on our system in phantom studies. And of course we are open to clinical publications.
